Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Testosterone × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Tumor-Agnostic 1 Lymphoid 1 Breast 1

Conditions

Breast Neoplasms 5 Dyspareunia 2 Arthralgia 2 Vaginitis 1 Sexual Dysfunction, Physiological 1 Osteoporosis 1 Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1

Interventions

Paclitaxel 24 pembrolizumab 22 Docetaxel 20 Capecitabine 18 Trastuzumab 16 Fulvestrant 14 Cyclophosphamide 14 Lapatinib 13 Anastrozole 12 Letrozole 10 Carboplatin 10 Therapeutics 9 Radiotherapy 9 Doxorubicin 9 Exercise 8 Cisplatin 8 Blood Specimen Collection 8 palbociclib 7 Nivolumab 7 Gemcitabine 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 Vinorelbine 6 Tamoxifen 6 Fluorouracil 6 atezolizumab 5 abemaciclib 5 Methods 5 Irinotecan 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00497458 2009-04-09

ART2

Havah Therapeutics Pty Ltd

Phase 2 Unknown

Breast Neoplasms, Neoplasms, Osteoporosis, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡